These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38765509)

  • 1. Non-RhD alloimmunization in pregnancy: an updated review.
    Ares SM; Nardozza LMM; Araujo Júnior E; Santana EFM
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
    Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
    AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka.
    Mandal S; Malhotra S; Negi G; Tiwari A; Mitra S; Basu S; Singh P
    Immunohematology; 2020 Jun; 36(2):60-63. PubMed ID: 32667819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
    Roubalová L; Lubušký M
    Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-anti-D antibodies in red-cell alloimmunization.
    Moise KJ
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
    Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
    Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
    Okwundu CI; Afolabi BB
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
    Babinszki A; Lapinski RH; Berkowitz RL
    Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization.
    Geaghan SM
    Semin Perinatol; 2011 Jun; 35(3):148-54. PubMed ID: 21641488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practices for RhD alloimmunization prevention: a vignette-based survey of midwives.
    Jourdren G; Berveiller P; Rousseau A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7629-7639. PubMed ID: 34433367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region].
    Holusková I; Lubušký M; Studničková M; Procházka M
    Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
    Hyland CA; O'Brien H; Flower RL; Gardener GJ
    Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province].
    Liu X; LE F; Wang LH; Shu J; Xu XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):215-220. PubMed ID: 36765502
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.